A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers

Abstract Background Human health and life are threatened by cancer with high morbidity and mortality worldwide. In many experiments, CDKN1B level is associated with cancer risk, Nevertheless, no pan-cancer analysis has been conducted on CDKN1B in human cancers. Methods With the help of bioinformatic...

Full description

Bibliographic Details
Main Authors: Hao Huang, Duoliang Qiu, Zhengyang Zhou, Biaobiao Wu, Lening Shao, Yuwei Pu, Tengfei He, Yongyou Wu, Dawei Cui, Fengyun Zhong
Format: Article
Language:English
Published: Springer 2023-07-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-023-00746-8
_version_ 1797778823986544640
author Hao Huang
Duoliang Qiu
Zhengyang Zhou
Biaobiao Wu
Lening Shao
Yuwei Pu
Tengfei He
Yongyou Wu
Dawei Cui
Fengyun Zhong
author_facet Hao Huang
Duoliang Qiu
Zhengyang Zhou
Biaobiao Wu
Lening Shao
Yuwei Pu
Tengfei He
Yongyou Wu
Dawei Cui
Fengyun Zhong
author_sort Hao Huang
collection DOAJ
description Abstract Background Human health and life are threatened by cancer with high morbidity and mortality worldwide. In many experiments, CDKN1B level is associated with cancer risk, Nevertheless, no pan-cancer analysis has been conducted on CDKN1B in human cancers. Methods With the help of bioinformatics, a pan-cancer analysis was conducted on the expression levels of CDKN1B in cancer tissues and adjacent tissues from the TCGA, CPTAC and GEO databases. The CDKN1B expression levels in tumor patients was further validated using immunohistochemistry (IHC) and quantitative real-time PCR. Results In the study, we first investigated the cancer-related roles of CDKN1B’s in 40 tumors with malignancy. The CDKN1B gene encodes the p27Kip1 protein, which can block the production cyclin-dependent kinase (CDK), which is obviously related to the function and survival of cancer cells and alters the prognosis of cancer patients. Furthermore, CDKN1B function requires both protein processing and RNA metabolism. Additionally, the elevated expression of the CDKN1B gene and protein was validated in several cancer tissues from the patients. Conclusions These results showed that the levels of CDKN1B were considerably different in a number of cancer tissues, offering a potential future target for cancer therapy.
first_indexed 2024-03-12T23:22:06Z
format Article
id doaj.art-3eaf7f06cb94483b8db3663cfc443ac8
institution Directory Open Access Journal
issn 2730-6011
language English
last_indexed 2024-03-12T23:22:06Z
publishDate 2023-07-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj.art-3eaf7f06cb94483b8db3663cfc443ac82023-07-16T11:20:22ZengSpringerDiscover Oncology2730-60112023-07-0114111510.1007/s12672-023-00746-8A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancersHao Huang0Duoliang Qiu1Zhengyang Zhou2Biaobiao Wu3Lening Shao4Yuwei Pu5Tengfei He6Yongyou Wu7Dawei Cui8Fengyun Zhong9Department of General Surgery, The Second Affiliated Hospital of Soochow UniversityDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital, Zhejiang University School of MedicineDepartment of General Surgery, The Second Affiliated Hospital of Soochow UniversityAbstract Background Human health and life are threatened by cancer with high morbidity and mortality worldwide. In many experiments, CDKN1B level is associated with cancer risk, Nevertheless, no pan-cancer analysis has been conducted on CDKN1B in human cancers. Methods With the help of bioinformatics, a pan-cancer analysis was conducted on the expression levels of CDKN1B in cancer tissues and adjacent tissues from the TCGA, CPTAC and GEO databases. The CDKN1B expression levels in tumor patients was further validated using immunohistochemistry (IHC) and quantitative real-time PCR. Results In the study, we first investigated the cancer-related roles of CDKN1B’s in 40 tumors with malignancy. The CDKN1B gene encodes the p27Kip1 protein, which can block the production cyclin-dependent kinase (CDK), which is obviously related to the function and survival of cancer cells and alters the prognosis of cancer patients. Furthermore, CDKN1B function requires both protein processing and RNA metabolism. Additionally, the elevated expression of the CDKN1B gene and protein was validated in several cancer tissues from the patients. Conclusions These results showed that the levels of CDKN1B were considerably different in a number of cancer tissues, offering a potential future target for cancer therapy.https://doi.org/10.1007/s12672-023-00746-8CDKN1BPan-cancerPrognosisCyclin-dependent kinaseGene
spellingShingle Hao Huang
Duoliang Qiu
Zhengyang Zhou
Biaobiao Wu
Lening Shao
Yuwei Pu
Tengfei He
Yongyou Wu
Dawei Cui
Fengyun Zhong
A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
Discover Oncology
CDKN1B
Pan-cancer
Prognosis
Cyclin-dependent kinase
Gene
title A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
title_full A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
title_fullStr A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
title_full_unstemmed A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
title_short A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
title_sort pan cancer analysis for the oncogenic role of cyclin dependent kinase inhibitor 1b in human cancers
topic CDKN1B
Pan-cancer
Prognosis
Cyclin-dependent kinase
Gene
url https://doi.org/10.1007/s12672-023-00746-8
work_keys_str_mv AT haohuang apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT duoliangqiu apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT zhengyangzhou apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT biaobiaowu apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT leningshao apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT yuweipu apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT tengfeihe apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT yongyouwu apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT daweicui apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT fengyunzhong apancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT haohuang pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT duoliangqiu pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT zhengyangzhou pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT biaobiaowu pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT leningshao pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT yuweipu pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT tengfeihe pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT yongyouwu pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT daweicui pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers
AT fengyunzhong pancanceranalysisfortheoncogenicroleofcyclindependentkinaseinhibitor1binhumancancers